Constitutive activation of central survival pathways as mitogen-activated protein kinases (MAPKs), protein kinase B (PKB/Akt) and nuclear factor-kappaB (NF-κ B) characteristically occur in cancer cells, and substantial evidence connects them with chemoresistance [77]. The gene discussed is AKT1; the disease is cancer.